The global Phase 3 MOTION study (NCT05059262) aims to evaluate the efficacy and safety of vimseltinib for the treatment of TGCT in cases where surgical removal of the tumor is not an option.

A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link ...

(NYSE: TXT) company has announced the first order of its best-selling Cessna Citation Latitude in Argentina. The aircraft, ...

Bobbi Brown Cosmetics is proud to announce actress, entrepreneur, and podcast host Sara Foster as its newest Global ...

Cinemo CARS™ Connect Direct lets passengers instantly connect their personal devices to the car’s infotainment system in just ...

Data revealed that while nearly all SAP customers surveyed are finding it difficult to make a positive ROI case for S/4HANA, ...

Beyon Cyber, part of the Beyon Group and the fastest growing cyber security company in the Middle East, has signed a ...

During Busworld Europe 2025 in Brussels, Karwa Motors LLC and Daimler Truck Middle East Africa signed a strategic partnership ...

The Estée Lauder Companies Inc. (NYSE:EL), today celebrated the sixtieth anniversary of its Manufacturing & Fulfillment ...

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for health, nutrition and bio industrial ...

“We are thrilled to be the launch customer for the Cessna Skyhawk Veris VR simulator,” said Mike Sykes, CEO and founder of US Aviation Academy. “Integrating the Veris into our training programs will ...

The HyperSpace Trackpad Pro (HS2510GL) will be available through Hyper’s Kickstarter campaign starting today with early bird ...